Direxion Daily S&P Biotech Bear 3X ETF
LABD$8.19 -0.40 (-4.66%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 30, 2026 | $0.08 | 2026-06-23 | 2026-06-23 |
| March 31, 2026 | $0.09 | 2026-03-24 | 2026-03-24 |
| December 31, 2025 | $0.23 | 2025-12-23 | 2025-12-23 |
| September 30, 2025 | $0.03 | 2025-09-23 | 2025-09-23 |
| July 1, 2025 | $0.04 | 2025-06-24 | 2025-06-24 |
Dividends Summary
- Consistent Payer: Direxion Daily S&P Biotech Bear 3X ETF has rewarded shareholders with 24 dividend payments over the past 8 years.
- Total Returned Value: Investors who held LABD shares during this period received a total of $2.10 per share in dividend income.
- Latest Payout: The most recent dividend of $0.08/share was paid 18 days ago, on June 30, 2026.
- Yield & Schedule: LABD currently pays dividends quarterly with an annual yield of 5.07%.
- Dividend Growth: Since 2018, the dividend payout has grown by 1594.4%, from $0.00 to $0.08.
Company News
5 Inverse ETFs That Gained More Than 20% in April
The U.S. stock market wrapped up April with losses, snapping a five-month winning streak and marking the market's worst month of 2024. This has resulted in huge gains for inverse or inverse-leveraged ETFs.
5 Best Inverse-Leveraged ETFs of Last Week
Last week witnessed the largest collective loss for the "Magnificent Seven" technology-related stocks, with a total of $950 billion erased from their market capitalizations.
Best Inverse/Leveraged ETFs of Last Week
Wall Street delivered a downbeat performance last week.
LABU: A Really Bad Drift
Leveraged ETFs have a non-linear, unpredictable behavior. Direxion Daily S&P Biotech Bull 3X Shares ETF is the worst. Find out why LABU ETF is a Sell.
